Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 23Breast Neoplasms 11Prostatic Neoplasms 10Stomach Neoplasms 7Carcinoma, Hepatocellular 6Small Cell Lung Carcinoma 4Melanoma 4Lymphoma 4Colorectal Neoplasms 4Uterine Cervical Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Neoplasms 3Multiple Pulmonary Nodules 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Disease 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Smoking Cessation 2Smoking 2Sarcopenia 2Recurrence 2Ovarian Neoplasms 2Neuroendocrine Tumors 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

gallium Ga 68 dotatate 1Tomography, X-Ray Computed 1Radionuclide Imaging 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Magnetic Resonance Imaging 1Health Personnel 1Caregivers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cancer Diagnosis × Tomography, X-Ray Computed × Clear all
NCT03125629 2021-04-09

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

Stanford University

Phase 2 Completed
53 enrolled 8 charts

Cancer Diagnosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡